loading
Precedente Chiudi:
$3.19
Aprire:
$3.25
Volume 24 ore:
848.59K
Relative Volume:
0.59
Capitalizzazione di mercato:
$481.78M
Reddito:
$288.95M
Utile/perdita netta:
$-119.03M
Rapporto P/E:
-3.7024
EPS:
-0.9005
Flusso di cassa netto:
$60.67M
1 W Prestazione:
+6.73%
1M Prestazione:
+24.72%
6M Prestazione:
+81.97%
1 anno Prestazione:
-58.43%
Intervallo 1D:
Value
$3.24
$3.46
Intervallo di 1 settimana:
Value
$3.12
$3.46
Portata 52W:
Value
$1.665
$8.535

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Name
Nome
Maravai Lifesciences Holdings Inc
Name
Telefono
(858) 546-0004
Name
Indirizzo
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Name
Dipendente
560
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-18
Name
Ultimi documenti SEC
Name
MRVI's Discussions on Twitter

Confronta MRVI con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MRVI
Maravai Lifesciences Holdings Inc
3.33 461.52M 288.95M -119.03M 60.67M -0.9005
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
406.76 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
472.17 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
551.62 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
809.47 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
331.09 35.16B 4.56B -176.77M 225.30M -1.7177

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-26 Downgrade Robert W. Baird Outperform → Neutral
2024-12-19 Iniziato Guggenheim Neutral
2024-12-05 Downgrade Goldman Neutral → Sell
2024-11-14 Iniziato Wolfe Research Peer Perform
2024-11-08 Downgrade William Blair Outperform → Mkt Perform
2024-08-28 Iniziato Wells Fargo Overweight
2024-08-13 Downgrade Morgan Stanley Overweight → Equal-Weight
2024-04-10 Iniziato Craig Hallum Buy
2023-12-12 Aggiornamento BofA Securities Neutral → Buy
2023-08-08 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
2023-05-23 Downgrade Credit Suisse Outperform → Neutral
2023-05-09 Downgrade Goldman Buy → Neutral
2023-01-05 Downgrade UBS Buy → Neutral
2022-12-14 Iniziato Deutsche Bank Buy
2022-12-07 Iniziato RBC Capital Mkts Outperform
2022-11-03 Downgrade BofA Securities Buy → Neutral
2022-08-25 Iniziato Credit Suisse Outperform
2021-08-05 Ripresa Credit Suisse Outperform
2020-12-16 Iniziato KeyBanc Capital Markets Overweight
2020-12-15 Iniziato BofA Securities Buy
2020-12-15 Iniziato Credit Suisse Outperform
2020-12-15 Iniziato Goldman Buy
2020-12-15 Iniziato Jefferies Buy
2020-12-15 Iniziato Robert W. Baird Outperform
2020-12-15 Iniziato Stifel Buy
2020-12-15 Iniziato William Blair Outperform
2020-12-14 Iniziato UBS Buy
Mostra tutto

Maravai Lifesciences Holdings Inc Borsa (MRVI) Ultime notizie

pulisher
09:48 AM

Has Maravai LifeSciences Holdings Inc. formed a bullish divergenceSell Signal & Daily Volume Surge Trade Alerts - newser.com

09:48 AM
pulisher
09:09 AM

Chart overlay techniques for tracking Maravai LifeSciences Holdings Inc.Gap Down & Stepwise Trade Signal Implementation - newser.com

09:09 AM
pulisher
08:18 AM

Tools to assess Maravai LifeSciences Holdings Inc.’s risk profileJuly 2025 Patterns & Real-Time Volume Trigger Notifications - newser.com

08:18 AM
pulisher
07:57 AM

Is Maravai LifeSciences Holdings Inc. stock ready for a breakout2025 AllTime Highs & Reliable Intraday Trade Alerts - newser.com

07:57 AM
pulisher
03:49 AM

Will Maravai LifeSciences Holdings Inc. stock outperform tech sector in 2025Entry Point & Expert Curated Trade Setup Alerts - newser.com

03:49 AM
pulisher
02:39 AM

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives Consensus Rating of “Hold” from Analysts - Defense World

02:39 AM
pulisher
01:43 AM

Will Maravai LifeSciences Holdings Inc. (MAR) stock beat growth indexesPortfolio Return Report & Free Accurate Trade Setup Notifications - newser.com

01:43 AM
pulisher
Oct 10, 2025

Why Maravai LifeSciences Holdings Inc. (MAR) stock appeals to dividend investorsBull Run & Safe Capital Growth Stock Tips - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Research Frontiers And 2 Other Promising Penny Stocks To Watch - simplywall.st

Oct 10, 2025
pulisher
Oct 10, 2025

Custom watchlist performance reports with Maravai LifeSciences Holdings Inc.Trend Reversal & Weekly High Conviction Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Detecting support and resistance levels for Maravai LifeSciences Holdings Inc.Portfolio Risk Report & Fast Exit and Entry Trade Guides - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out - ACCESS Newswire

Oct 09, 2025
pulisher
Oct 09, 2025

What data driven models say about Maravai LifeSciences Holdings Inc.’s futureWeekly Investment Report & Technical Confirmation Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

How high can Maravai LifeSciences Holdings Inc. stock goJuly 2025 Opening Moves & Safe Entry Zone Tips - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Multi asset correlation models including Maravai LifeSciences Holdings Inc. - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

How to interpret RSI for Maravai LifeSciences Holdings Inc. stockGap Down & Weekly Setup with High ROI Potential - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

How hedge fund analytics apply to Maravai LifeSciences Holdings Inc. stockTrend Reversal & Safe Investment Capital Preservation Plans - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Maravai LifeSciences stock plunges 39% amid lowered revenue forecast - MSN

Oct 08, 2025
pulisher
Oct 07, 2025

Maravai LifeSciences (NASDAQ:MRVI) Trading 5.9% HigherShould You Buy? - MarketBeat

Oct 07, 2025
pulisher
Oct 06, 2025

What’s next for Maravai LifeSciences Holdings Inc. stock priceGap Down & Low Drawdown Momentum Ideas - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Maravai LifeSciences Holdings Inc.’s volatility index tracking explainedJuly 2025 Final Week & Expert Approved Trade Ideas - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Tools to monitor Maravai LifeSciences Holdings Inc. recovery probabilityQuarterly Market Summary & AI Powered Market Entry Strategies - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is Maravai LifeSciences Holdings Inc. stock entering bullish territory2025 Trading Recap & Risk Controlled Stock Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

How supply shortages influence Maravai LifeSciences Holdings Inc. (MAR) stockWeekly Stock Analysis & Daily Entry Point Trade Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Using Python tools to backtest Maravai LifeSciences Holdings Inc. strategiesStock Surge & Verified Short-Term Plans - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

Maravai postpones earnings release, delays annual report - MSN

Oct 04, 2025
pulisher
Oct 03, 2025

Avantor, Inc. Appoints Gregory T. Lucier to Its Board of Directors - MarketScreener

Oct 03, 2025
pulisher
Oct 03, 2025

Key resistance and support levels for Maravai LifeSciences Holdings Inc.2025 Risk Factors & Safe Capital Allocation Plans - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

MARAVAI (MRVI) INVESTIGATION ALERT: Bragar Eagel & Squire, - GlobeNewswire

Oct 02, 2025
pulisher
Oct 02, 2025

Voya Investment Management LLC Reduces Holdings in Maravai LifeSciences Holdings, Inc. $MRVI - Defense World

Oct 02, 2025
pulisher
Oct 02, 2025

Maravai LifeSciences Sees Unusually Large Options Volume (NASDAQ:MRVI) - MarketBeat

Oct 02, 2025
pulisher
Sep 30, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Connect - ACCESS Newswire

Sep 30, 2025
pulisher
Sep 30, 2025

What drives Maravai LifeSciences Holdings Inc stock priceGrowth vs. Value Investing & Build a Dividend-Powered Portfolio - earlytimes.in

Sep 30, 2025

Maravai Lifesciences Holdings Inc Azioni (MRVI) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$84.60
price up icon 0.95%
$22.86
price up icon 6.98%
$32.47
price up icon 2.06%
$102.55
price up icon 0.63%
$166.10
price up icon 2.22%
biotechnology ONC
$331.09
price up icon 3.45%
Capitalizzazione:     |  Volume (24 ore):